Get the Stockscreener App
1.82
1.69%
-0.0312
After Hours:
1.85
0.03
+1.65%
Qualigen Therapeutics Inc stock is traded at $1.82, with a volume of 11,906.
It is down -1.69% in the last 24 hours and down -35.00% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$1.8512
Open:
$1.85
24h Volume:
11,906
Relative Volume:
0.02
Market Cap:
$3.09M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
-0.6842
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
-3.45%
1M Performance:
-35.00%
6M Performance:
-43.83%
1Y Performance:
-81.87%
1-Day Range:
$1.82
$1.86
1-Week Range:
$1.82
$1.90
52-Week Range:
$1.61
$10.45
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
1.82 | 3.14M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
How to track smart money flows in Qualigen Therapeutics Inc.Earnings Summary Report & Detailed Earnings Play Alerts - Newser
Qualigen Therapeutics Amends Promissory Note with Marizyme - TipRanks
Chart based analysis of Qualigen Therapeutics Inc. trendsBull Run & Stepwise Swing Trade Plans - Newser
Volume spikes in Qualigen Therapeutics Inc. stock – what they meanJuly 2025 Volume & Comprehensive Market Scan Reports - Newser
Does Qualigen Therapeutics Inc. fit your quant trading modelMarket Movers & Daily Volume Surge Trade Alerts - Newser
Will Qualigen Therapeutics Inc. Benefit From Broader Market BounceJuly 2025 Breakouts & Risk Adjusted Buy and Sell Alerts - beatles.ru
What MACD signals say about Qualigen Therapeutics Inc.Weekly Trade Report & Community Shared Stock Ideas - Newser
Visual analytics tools that track Qualigen Therapeutics Inc. performanceJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Building trade automation scripts for Qualigen Therapeutics Inc.July 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Will breakout in Qualigen Therapeutics Inc. lead to full recoveryJuly 2025 Patterns & AI Forecast Swing Trade Picks - Newser
Detecting price anomalies in Qualigen Therapeutics Inc. with AIOil Prices & AI Forecast Swing Trade Picks - Newser
Historical volatility pattern of Qualigen Therapeutics Inc. visualizedJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - Newser
Can momentum traders help lift Qualigen Therapeutics Inc.Weekly Trend Summary & Fast Gaining Stock Strategy Reports - Newser
Hedge Fund Bets: Can Qualigen Therapeutics Inc. generate free cash flowPortfolio Risk Summary & Fast Moving Market Watchlists - theviewers.co.kr
Is Qualigen Therapeutics Inc. forming bullish engulfing patterns2025 Bull vs Bear & Free Low Drawdown Momentum Trade Ideas - kpenews.com
Intraday pattern recognizer results for Qualigen Therapeutics Inc.Earnings Risk Report & Risk Controlled Swing Trade Alerts - Newser
Bear Alert: Will Qualigen Therapeutics Inc. benefit from sector rotationQuarterly Investment Review & Comprehensive Market Scan Reports - sundaytimes.kr
Is Qualigen Therapeutics Inc. a strong growth stock2025 Market Outlook & AI Based Buy and Sell Signals - kpenews.com
Is Qualigen Therapeutics Inc. vulnerable to short sellersMarket Trend Summary & Short-Term Trading Opportunity Alerts - theviewers.co.kr
Multi Factor Analysis Ranks Qualigen Therapeutics Inc. as Strong Buy2025 Market Sentiment & Verified Chart Pattern Trade Signals - mustnews.co.kr
What’s Qualigen Therapeutics Inc.’s historical returnTrade Entry Summary & Target Return Focused Picks - sundaytimes.kr
Sector ETF performance correlation with Qualigen Therapeutics Inc.July 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Qualigen Therapeutics Inc. Bounces Off Moving Average SupportPortfolio Return Report & Verified Momentum Stock Ideas - classian.co.kr
Will Qualigen Therapeutics Inc. benefit from sector rotationWeekly Investment Report & Real-Time Stock Price Movement Reports - newsyoung.net
Will Qualigen Therapeutics Inc. continue its uptrendEarnings Summary Report & Weekly Market Pulse Updates - Newser
Chart Patterns Forming a Bullish Setup in Qualigen Therapeutics Inc.GDP Growth & Free Weekly Chart Analysis and Trade Guides - metal.it
Full technical analysis of Qualigen Therapeutics Inc. stockQuarterly Earnings Summary & Real-Time Volume Analysis - Newser
Qualigen Therapeutics, Inc. SEC 10-Q Report - TradingView
Using data filters to optimize entry into Qualigen Therapeutics Inc.Chart Signals & Long-Term Investment Growth Plans - Newser
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):